Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
Singh M, Williams BA, Gersh BJ, McClelland RL, Ho KK, Willerson JT, Penny WF, Cutlip DE, Holmes DR Jr. Singh M, et al. Among authors: cutlip de. J Am Coll Cardiol. 2006 Jan 3;47(1):34-9. doi: 10.1016/j.jacc.2005.07.066. J Am Coll Cardiol. 2006. PMID: 16386661 Free article.
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.
Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Clark MR, Cohen BM, Ellis SG, Coleman P, Hill C, Shi C, Cutlip DE, Kuntz RE, Moses JW. Weisz G, et al. Among authors: cutlip de. J Am Coll Cardiol. 2006 Apr 4;47(7):1350-5. doi: 10.1016/j.jacc.2005.11.077. Epub 2006 Mar 20. J Am Coll Cardiol. 2006. PMID: 16580520 Free article.
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.
Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Holmes DR Jr, et al. Circulation. 2004 Feb 10;109(5):634-40. doi: 10.1161/01.CIR.0000112572.57794.22. Circulation. 2004. PMID: 14769686 Clinical Trial.
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry.
Cutlip DE, Leon MB, Ho KK, Gordon PC, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Fitzpatrick MM, Desjardin A, Popma JJ, Kuntz RE, Baim DS. Cutlip DE, et al. J Am Coll Cardiol. 1999 Sep;34(3):698-706. doi: 10.1016/s0735-1097(99)00271-5. J Am Coll Cardiol. 1999. PMID: 10483950 Free article. Clinical Trial.
Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).
Whitlow PL, Bass TA, Kipperman RM, Sharaf BL, Ho KK, Cutlip DE, Zhang Y, Kuntz RE, Williams DO, Lasorda DM, Moses JW, Cowley MJ, Eccleston DS, Horrigan MC, Bersin RM, Ramee SR, Feldman T. Whitlow PL, et al. Among authors: cutlip de. Am J Cardiol. 2001 Mar 15;87(6):699-705. doi: 10.1016/s0002-9149(00)01486-7. Am J Cardiol. 2001. PMID: 11249886 Clinical Trial.
Effects of stent length and lesion length on coronary restenosis.
Mauri L, O'Malley AJ, Cutlip DE, Ho KK, Popma JJ, Chauhan MS, Baim DS, Cohen DJ, Kuntz RE. Mauri L, et al. Among authors: cutlip de. Am J Cardiol. 2004 Jun 1;93(11):1340-6, A5. doi: 10.1016/j.amjcard.2004.02.027. Am J Cardiol. 2004. PMID: 15165911
296 results